Molecular Formula | C26H26N6O2S |
Molar Mass | 486.59 |
Density | 1.336±0.06 g/cm3(Predicted) |
Solubility | DMSO: ≥ 44 mg/mL |
pKa | 12.87±0.70(Predicted) |
Storage Condition | -20℃ |
In vitro study | HM61713 has potent inhibitory effects in the cell lines H1975(L858R and T790M EGFR) and HCC827(exon 19 delete EGFR). However, the inhibitory effect on the NSCLC cell line H358 carrying wild-type EGFR was relatively weak (IC50=2225 nM). |
In vivo study | The Half-Life of EGFR inhibition by HM61713 exceeds 24 hours. In an intratumoral model transplanted with H1975 and HCC827 cells, HM61713 had antitumor effects without other significant side effects. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.055 ml | 10.276 ml | 20.551 ml |
5 mM | 0.411 ml | 2.055 ml | 4.11 ml |
10 mM | 0.206 ml | 1.028 ml | 2.055 ml |
5 mM | 0.041 ml | 0.206 ml | 0.411 ml |